Cite
HARVARD Citation
Dolin, P. et al. (n.d.). P657 Current landscape of the real-world utilization of Interleukins 22, 23 and Interleukin 22 binding protein as biomarkers for Inflammatory Bowel Disease (IBD): A targeted literature review. Journal of Crohn's and colitis. pp. i784-i785. [Online].